Clenpiq Patent Expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US11191753 FERRING PHARMS INC Liquid pharmaceutical composition
Jun, 2034

(9 years from now)

US10624879 FERRING PHARMS INC Liquid pharmaceutical composition
Jun, 2034

(9 years from now)

US9827231 FERRING PHARMS INC Liquid pharmaceutical composition
Jun, 2034

(9 years from now)



Clenpiq is a drug owned by Ferring Pharmaceuticals Inc. It is used for bowel preparation for colonoscopies. Clenpiq uses Citric Acid; Magnesium Oxide; Sodium Picosulfate as an active ingredient. Clenpiq was launched by Ferring Pharms Inc in 2017. It is is available in solution form for oral use. Its generic launch date based on the last expiry date of its patents and exclusivities combined is estimated to be Jun 26, 2034 (This date is subject to change depending upon the patent filing activities by the drug owner or exclusivity additions to its drug application)

Drug Exclusivity Drug Exclusivity Expiration
New Patient Population(NPP) Aug 15, 2021

Stay ahead of others in designing the generic launch strategy of these 5 blockbuster drugs expiring in next 5 years.

Get the exclusive patent insights now. Don't be the last to know.

Drugs and Companies using CITRIC ACID; MAGNESIUM OXIDE; SODIUM PICOSULFATE ingredient

Market Authorisation Date: 28 November, 2017

Treatment: For cleansing of the colon as a preparation for colonoscopy; For cleansing the large intestine as a preparation for colonoscopy

Dosage: SOLUTION

How can I launch a generic of CLENPIQ before it's drug patent expiration?
More Information on Dosage

CLENPIQ family patents

Family Patents